Timber Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
For the nine months, revenue was USD 0.083177 million compared to USD 0.696527 million a year ago. Net loss was USD 15.76 million compared to USD 7.85 million a year ago. Basic loss per share from continuing operations was USD 10.16 compared to USD 11.09 a year ago.